Finally a soluble CCR2-Ig that selectively neutralizes CCL2 [20] was then used to determine the direct contribution of the autocrine interaction of CCL2-CCR2 on the cancer cells to tumor growth. The gene discussed is CCL2; the disease is neoplasm.